Loading company…
Omniome, Inc. is a San Diego biotech company developing DNA sequencing technology for cancer diagnostics.
Omniome, Inc. develops DNA sequencing technologies for cancer diagnostics and sells them to organizations engaged in clinical sequencing. Its Sequencing By Binding (SBB) technology is designed to improve the precision of nucleotide and DNA matching. Founded in 2013 in California, US, the company raised USD 60 million in Series C funding led by Madrone Capital Partners in 2019. Pacific Biosciences of California, Inc. signed an agreement to acquire it in July 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in